GALT 10-Q: SEC filing

Galectin Therapeutics

Filed with the SEC on · accession 0001140361-26-043988

GALT filed a 10-Q (quarterly report) with the SEC on Nov 16, 2026. The quarterly report: unaudited results for the quarter plus management’s comments.

Summary of the filing

Galectin Therapeutics filed its quarterly 10-Q report for the period ended September 30, 2026, disclosing a significant decline in cash and a substantial increase in related-party convertible debt and derivative liabilities.

Key details

Cash and cash equivalents as of September 30, 2026$11.7M
Cash and cash equivalents as of December 31, 2025$17.7M
Total current liabilities as of September 30, 2026$46.4M
Total liabilities as of September 30, 2026$46.4M
Convertible notes payable and accrued interest, net of debt discounts - related party (current) as of September 30, 2026$33.2M
Derivative liabilities (current) as of September 30, 2026$5.5M
Borrowing and accrued interest under convertible line of credit, net of debt discount - related party as of December 31, 2025$101.0M
FilerGalectin Therapeutics Inc.

✦ Ask GOAX AI about this filing — what it means for GALT, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for GALT?

Click here

Frequently asked questions

What did GALT file with the SEC on Nov 16, 2026?

GALT filed a 10-Q (SEC filing). Galectin Therapeutics filed its quarterly 10-Q report for the period ended September 30, 2026, disclosing a significant decline in cash and a substantial increase in related-party convertible debt and derivative liabilities.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

Other GALT SEC filings

Get alerts when GALT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days